Glycine

Glycine

SCHEMBL700064

Cl.Cl.Cl.Cl.Cl.Cl.Cl.NCC(=O)[O-].NCC(=O)[O-].NCC(=O)[O-].NCC(=O)[O-].NCC(=O)[O-].NCC(=O)[O-].NCC(=O)[O-].[Al+3].[Zr+4]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA4 P22748 3/20 0.41
GLRA1 P23415 1/20 0.41
SLC6A9 P48067 1/20 0.41
OR51E2 Q9H255 1/20 0.41
CASP1 P29466 1/20 0.37
FFAR3 O14843 2/20 0.33
HDAC3 O15379 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC2 Q92769 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
MEN1 O00255 1/20 0.32
LDHA P00338 1/20 0.32
BLM P54132 1/20 0.32
KMT2A Q03164 1/20 0.32
GABRR1 P24046 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL3267690 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL9019048 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL599169 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL699842 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL5472175 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL5478239 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL3028174 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL1933545 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL10433486 0.97 CA4 (0.39) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL2025189 0.96 CA4 (0.44) CA4GLRA1SLC6A9OR51E2CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8349339-B2 Antiperspirant or deodorant compositions CONOPCO INC. (US) 2013-01-08 US claimed
US-20060134037-A1 Antiperspirant or deodorant compositions CONOPCO INC, D/B/A UNILEVER 2006-06-22 US claimed
US-9981149-B2 Highly active antiperspirant with improved skin tolerability HENKEL AG & CO. KGAA (DE) 2018-05-29 US disclosed
US-20170348551-A1 HIGHLY ACTIVE ANTIPERSPIRANT WITH IMPROVED SKIN TOLERABILITY HENKEL AG & CO. KGAA (DE) 2017-12-07 US disclosed
US-9549883-B2 Textile friendly nonaerosol-antiperspirants with methansulfonic HENKEL AG & CO. KGAA (DE) 2017-01-24 US disclosed
US-9186304-B2 Peg-free antiperspirant oil-in-water emulsions having improved feel HENKEL AG & CO. KGAA (DE) 2015-11-17 US disclosed
US-9095520-B2 Textile friendly non-aerosol antiperspirants with a hydroxy acid HENKEL AG & CO. KGAA (DE) 2015-08-04 US disclosed
US-20150086499-A1 THICKENED ANTIPERSPIRANT ROLL-ONS HAVING AN IMPROVED RESIDUE BEHAVIOR HENKEL AG & CO. KGAA (DE) 2015-03-26 US disclosed
US-20140301963-A1 PEG-FREE ANTIPERSPIRANT OIL-IN-WATER EMULSIONS HAVING IMPROVED FEEL HENKEL AG & CO. KGAA (DE) 2014-10-09 US disclosed
US-20140173833-A1 TEXTILE FRIENDLY NONAEROSOL-ANTIPERSPIRANTS WITH METHANSULFONIC HENKEL AG & CO. KGAA (DE) 2014-06-26 US disclosed
US-20140178321-A1 TEXTILE FRIENDLY NON-AEROSOL ANTIPERSPIRANTS WITH A HYDROXY ACID HENKEL AG & CO. KGAA (DE) 2014-06-26 US disclosed
US-20100150856-A1 STABILIZED AQUEOUS ALUMINUM ZIRCONIUM SOLUTIONS SOMERVILLE TECHNOLOGY GROUP, INC. D/B/A SUMMIT RESEARCH LABS (US) 2010-06-17 US disclosed
US-7731943-B2 Stabilized aqueous aluminum zirconium solutions SUMMIT RESEARCH LABS, INC. (US) 2010-06-08 US disclosed
US-20090047226-A1 Quick-drying cosmetic emulsions for roll-on application HENKEL AG & C. KGAA (DE) 2009-02-19 US disclosed
US-7294330-B2 prevent decomposition of steroid ester; inhibit odors HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-11-13 US disclosed
US-20070253922-A1 ANHYDROUS ANTIPERSPIRANT/DEODORANT STICK COMPOSITIONS KAO CORPORATION (JP) 2007-11-01 US disclosed
US-20060008435-A1 Stabilized aqueous aluminum zirconium solutions SOMERVILLE TECHNOLOGY GROUP, INC. D/B/A SUMMIT RESEARCH LABS (US) 2006-01-12 US disclosed
WO-2005117812-A1 STABILIZED AQUEOUS ALUMINUM ZIRCONIUM SOLUTIONS SOMERVILLE TECHNOLOGY GROUP, INC. (US) 2005-12-15 WO disclosed
US-20040234466-A1 Beta-glucuronidase inhibitors for use in deodorants and antiperspirants HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2004-11-25 US disclosed
US-20040170670-A1 Cosmetic sponges REGENESIS LLC 2004-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140301963-A1 PEG-FREE ANTIPERSPIRANT OIL-IN-WATER EMULSIONS HAVING IMPROVED FEEL GGCT, GLUL, PPARG CA4 2898/4885GLRA1 123/4885SLC6A9 720/4885
US-20040234466-A1 Beta-glucuronidase inhibitors for use in deodorants and antiperspirants GUSB, PON1, IDUA CA4 437/4885GLRA1 912/4885SLC6A9 1083/4885
US-20090047226-A1 Quick-drying cosmetic emulsions for roll-on application CUTA, UGCG, MGLL CA4 4633/4885GLRA1 2676/4885SLC6A9 3777/4885
US-20140178321-A1 TEXTILE FRIENDLY NON-AEROSOL ANTIPERSPIRANTS WITH A HYDROXY ACID HRH1, NCEH1, HCAR1 CA4 2501/4885GLRA1 841/4885SLC6A9 3484/4885
US-20140173833-A1 TEXTILE FRIENDLY NONAEROSOL-ANTIPERSPIRANTS WITH METHANSULFONIC TST, MPST, CUTA CA4 3664/4885GLRA1 3049/4885SLC6A9 1232/4885
US-20060134037-A1 Antiperspirant or deodorant compositions DECR1, ADH1A, GDI2 CA4 3533/4885GLRA1 1073/4885SLC6A9 1243/4885
US-20040170670-A1 Cosmetic sponges CUTA, SUCLG1, AQP3 CA4 2857/4885GLRA1 4103/4885SLC6A9 3737/4885
US-20070253922-A1 ANHYDROUS ANTIPERSPIRANT/DEODORANT STICK COMPOSITIONS DRD4, DRD1, DRD2 CA4 1434/4885GLRA1 2885/4885SLC6A9 1357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.